Ticker

Analyst Price Targets — MOLN

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
January 27, 2026 11:06 amH.C. Wainwright$13.00$4.00TheFly Molecular Partners initiated with a Buy at H.C. Wainwright
April 27, 2022 6:21 amLeerink Partners$29.00$13.89Benzinga SVB Leerink Maintains Outperform on Molecular Partners, Lowers Price Target to $29

Latest News for MOLN

Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced its attendance and presentations at upcoming investor conferences.

GlobeNewsWire • Feb 26, 2026
Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced the presentation of first patient imaging and dosimetry data of…

GlobeNewsWire • Feb 2, 2026
Molecular Partners Highlights Clinical Development Progress and Anticipated Milestones at 44th Annual J.P. Morgan Healthcare Conference

Phase 1/2a study with lead Radio-DARPin MP0712 initiated; first patient dosing expected Q1 2026, initial data anticipated in 2026 Full imaging and dosimetry data from MP0712 compassionate care program to be presented at TWC 2026 Phase 2 investigator-initiated trial of MP0317 now open with patient dosing ongoing, exploring MP0317 in combination with standard-of-care for patients with cholangiocarcinoma Phase 1/2a…

Globe News Wire • Jan 11, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for MOLN.

No Senate trades found for MOLN.

No House trades found for MOLN.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top